Purpose
This study was performed to compare the clinical results and radiological follow-up differences between intertrochanteric fractures treated with the U-blade Gamma3 nail or the Zimmer natural nail (ZNN).
Materials and Methods
The medical records of 129 cases diagnosed with an intertrochanteric frac-ture (90 cases of U-blade Gamma3 nail, 39 cases of ZNN) from July 2015 to December 2018 were reviewed. Patients were assigned to a U-blade Gamma3 nail (n=39) or a ZNN (n=39) group. To reduce selective bias, groups were subjected to Propensity score matching by age, body mass index, bone mineral density, and fracture type. Patients that met the following criteria were excluded; age <65 years, non-ambulatory, high energy or pathologic fracture, and a follow-up of <6 months. Operation times, estimated blood losses, preoperative and postoperative Koval grades, Harris hip score and radiological lag screw positions in the femoral head, reduction quality, cut-out, tip-apex distance (TAD), lag screw sliding distances, and times to union were compared.
Results
Clinical results were similar in the two groups, but lag screw TAD was significantly greater in Ublade Gamma3 nail group (23.4 mm vs. 21.0 mm) (p=0.042). One case of cut-out occurred in the Ublade Gamma3 nail group, but no other nail-related postoperative complication was noted.
Conclusion
No significant difference was observed between the outcomes of U-blade Gamma3 nail or ZNN treatments of intertrochanteric fractures. We conclude that the U-blade confers no specific advan-tage.
This study was performed to compare the clinical results and radiological follow-up differences between intertrochanteric fractures treated with the U-blade Gamma3 nail or the Zimmer natural nail (ZNN).
The medical records of 129 cases diagnosed with an intertrochanteric fracture (90 cases of U-blade Gamma3 nail, 39 cases of ZNN) from July 2015 to December 2018 were reviewed. Patients were assigned to a U-blade Gamma3 nail (n=39) or a ZNN (n=39) group. To reduce selective bias, groups were subjected to Propensity score matching by age, body mass index, bone mineral density, and fracture type. Patients that met the following criteria were excluded; age <65 years, non-ambulatory, high energy or pathologic fracture, and a follow-up of <6 months. Operation times, estimated blood losses, preoperative and postoperative Koval grades, Harris hip score and radiological lag screw positions in the femoral head, reduction quality, cut-out, tip-apex distance (TAD), lag screw sliding distances, and times to union were compared.
Clinical results were similar in the two groups, but lag screw TAD was significantly greater in U-blade Gamma3 nail group (23.4 mm vs. 21.0 mm) (p=0.042). One case of cut-out occurred in the U-blade Gamma3 nail group, but no other nail-related postoperative complication was noted.
No significant difference was observed between the outcomes of U-blade Gamma3 nail or ZNN treatments of intertrochanteric fractures. We conclude that the U-blade confers no specific advantage.
Fig. 1
(A) Anteroposterior view of an intertrochanteric fracture treated with a U-blade Gamma3 nail. (B) Trans-Lateral view of an intertrochanteric fracture treated with a U-blade Gamma3 nail. (C) Photograph of a U-blade Gamma3 nail.
Fig. 2
(A) Anteroposterior view of an intertrochanteric fracture treated with a Zimmer natural nail. (B) Trans-lateral view of an intertrochanteric fracture treated with a Zimmer natural nail. (C) Photograph of a Zimmer natural nail.
Fig. 3
(A, B) Preoperative anteroposterior and trans-lateral radiographs of an intertrochanteric fracture in a 97-year-old man classified as AO A2.2. (C, D) Postoperative anteroposterior and translateral radiographs showing the U-blade Gamma3 nail.
Fig. 4
(A) Anteroposterior radiographs taken at one year postoperatively of a 97-year-old man treated with a U-blade Gamma3 nail showing fixation failure and blade cut-out through the femoral head into the acetabulum. (B) Revision total hip arthroplasty enabled the patient to walk independently.
Table 1
Demographic Characteristics
Table 2
Comparison of Clinical Results
Table 3
Comparison of the Radiographic Results
Financial support:None.
Conflict of interests:None.